Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia

S. Matsumoto, K. Sekine, H. Funaoka, M. Yamazaki, M. Shimizu, Kei Hayashida, M. Kitano

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: The aim of this study was to evaluate the use of intestinal fatty acid binding protein (I-FABP) and traditional biomarkers in the early diagnosis of acute intestinal ischaemia of different causes. Methods: I-FABP, white blood cell (WBC) count, C-reactive protein, base deficit, lactate, lactate dehydrogenase, aspartate aminotransferase, creatine kinase and D-dimer were measured prospectively in consecutive patients suspected of having acute intestinal ischaemia. Biomarker levels were compared in patients with vascular and non-vascular ischaemia. Results: Two hundred and eight patients with a clinical suspicion of acute intestinal ischaemia were enrolled. Vascular intestinal ischaemia was diagnosed in 24 patients (11·5 per cent), non-vascular ischaemia in 62 (29·8 per cent) and non-ischaemic disease in 122 (58·7 per cent). The levels of most biomarkers (except WBC count and creatine kinase) were significantly higher in the vascular ischaemia group than in the other groups (P < 0·010). However, none of the biomarker levels differed between patients with non-vascular intestinal ischaemia and those with non-ischaemic disease. Receiver operating characteristic (ROC) curve analysis suggested that I-FABP was best at diagnosing vascular intestinal ischaemia (area under the curve 0·88). Conclusion: Serum biomarkers may be useful in the diagnosis of vascular, but not non-vascular, intestinal ischaemia.

Original languageEnglish
Pages (from-to)232-238
Number of pages7
JournalBritish Journal of Surgery
Volume101
Issue number3
DOIs
Publication statusPublished - 2014 Feb 1
Externally publishedYes

Fingerprint

Ischemia
Biomarkers
Blood Vessels
Fatty Acid-Binding Proteins
Creatine Kinase
Leukocyte Count
Aspartate Aminotransferases
L-Lactate Dehydrogenase
ROC Curve
C-Reactive Protein
Area Under Curve
Early Diagnosis
Lactic Acid
Serum

ASJC Scopus subject areas

  • Surgery

Cite this

Matsumoto, S., Sekine, K., Funaoka, H., Yamazaki, M., Shimizu, M., Hayashida, K., & Kitano, M. (2014). Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. British Journal of Surgery, 101(3), 232-238. https://doi.org/10.1002/bjs.9331

Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. / Matsumoto, S.; Sekine, K.; Funaoka, H.; Yamazaki, M.; Shimizu, M.; Hayashida, Kei; Kitano, M.

In: British Journal of Surgery, Vol. 101, No. 3, 01.02.2014, p. 232-238.

Research output: Contribution to journalArticle

Matsumoto, S, Sekine, K, Funaoka, H, Yamazaki, M, Shimizu, M, Hayashida, K & Kitano, M 2014, 'Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia', British Journal of Surgery, vol. 101, no. 3, pp. 232-238. https://doi.org/10.1002/bjs.9331
Matsumoto S, Sekine K, Funaoka H, Yamazaki M, Shimizu M, Hayashida K et al. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. British Journal of Surgery. 2014 Feb 1;101(3):232-238. https://doi.org/10.1002/bjs.9331
Matsumoto, S. ; Sekine, K. ; Funaoka, H. ; Yamazaki, M. ; Shimizu, M. ; Hayashida, Kei ; Kitano, M. / Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. In: British Journal of Surgery. 2014 ; Vol. 101, No. 3. pp. 232-238.
@article{2e07551a1af6405195ec97f965bbaad2,
title = "Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia",
abstract = "Background: The aim of this study was to evaluate the use of intestinal fatty acid binding protein (I-FABP) and traditional biomarkers in the early diagnosis of acute intestinal ischaemia of different causes. Methods: I-FABP, white blood cell (WBC) count, C-reactive protein, base deficit, lactate, lactate dehydrogenase, aspartate aminotransferase, creatine kinase and D-dimer were measured prospectively in consecutive patients suspected of having acute intestinal ischaemia. Biomarker levels were compared in patients with vascular and non-vascular ischaemia. Results: Two hundred and eight patients with a clinical suspicion of acute intestinal ischaemia were enrolled. Vascular intestinal ischaemia was diagnosed in 24 patients (11·5 per cent), non-vascular ischaemia in 62 (29·8 per cent) and non-ischaemic disease in 122 (58·7 per cent). The levels of most biomarkers (except WBC count and creatine kinase) were significantly higher in the vascular ischaemia group than in the other groups (P < 0·010). However, none of the biomarker levels differed between patients with non-vascular intestinal ischaemia and those with non-ischaemic disease. Receiver operating characteristic (ROC) curve analysis suggested that I-FABP was best at diagnosing vascular intestinal ischaemia (area under the curve 0·88). Conclusion: Serum biomarkers may be useful in the diagnosis of vascular, but not non-vascular, intestinal ischaemia.",
author = "S. Matsumoto and K. Sekine and H. Funaoka and M. Yamazaki and M. Shimizu and Kei Hayashida and M. Kitano",
year = "2014",
month = "2",
day = "1",
doi = "10.1002/bjs.9331",
language = "English",
volume = "101",
pages = "232--238",
journal = "British Journal of Surgery",
issn = "0007-1323",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia

AU - Matsumoto, S.

AU - Sekine, K.

AU - Funaoka, H.

AU - Yamazaki, M.

AU - Shimizu, M.

AU - Hayashida, Kei

AU - Kitano, M.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Background: The aim of this study was to evaluate the use of intestinal fatty acid binding protein (I-FABP) and traditional biomarkers in the early diagnosis of acute intestinal ischaemia of different causes. Methods: I-FABP, white blood cell (WBC) count, C-reactive protein, base deficit, lactate, lactate dehydrogenase, aspartate aminotransferase, creatine kinase and D-dimer were measured prospectively in consecutive patients suspected of having acute intestinal ischaemia. Biomarker levels were compared in patients with vascular and non-vascular ischaemia. Results: Two hundred and eight patients with a clinical suspicion of acute intestinal ischaemia were enrolled. Vascular intestinal ischaemia was diagnosed in 24 patients (11·5 per cent), non-vascular ischaemia in 62 (29·8 per cent) and non-ischaemic disease in 122 (58·7 per cent). The levels of most biomarkers (except WBC count and creatine kinase) were significantly higher in the vascular ischaemia group than in the other groups (P < 0·010). However, none of the biomarker levels differed between patients with non-vascular intestinal ischaemia and those with non-ischaemic disease. Receiver operating characteristic (ROC) curve analysis suggested that I-FABP was best at diagnosing vascular intestinal ischaemia (area under the curve 0·88). Conclusion: Serum biomarkers may be useful in the diagnosis of vascular, but not non-vascular, intestinal ischaemia.

AB - Background: The aim of this study was to evaluate the use of intestinal fatty acid binding protein (I-FABP) and traditional biomarkers in the early diagnosis of acute intestinal ischaemia of different causes. Methods: I-FABP, white blood cell (WBC) count, C-reactive protein, base deficit, lactate, lactate dehydrogenase, aspartate aminotransferase, creatine kinase and D-dimer were measured prospectively in consecutive patients suspected of having acute intestinal ischaemia. Biomarker levels were compared in patients with vascular and non-vascular ischaemia. Results: Two hundred and eight patients with a clinical suspicion of acute intestinal ischaemia were enrolled. Vascular intestinal ischaemia was diagnosed in 24 patients (11·5 per cent), non-vascular ischaemia in 62 (29·8 per cent) and non-ischaemic disease in 122 (58·7 per cent). The levels of most biomarkers (except WBC count and creatine kinase) were significantly higher in the vascular ischaemia group than in the other groups (P < 0·010). However, none of the biomarker levels differed between patients with non-vascular intestinal ischaemia and those with non-ischaemic disease. Receiver operating characteristic (ROC) curve analysis suggested that I-FABP was best at diagnosing vascular intestinal ischaemia (area under the curve 0·88). Conclusion: Serum biomarkers may be useful in the diagnosis of vascular, but not non-vascular, intestinal ischaemia.

UR - http://www.scopus.com/inward/record.url?scp=84893662233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893662233&partnerID=8YFLogxK

U2 - 10.1002/bjs.9331

DO - 10.1002/bjs.9331

M3 - Article

VL - 101

SP - 232

EP - 238

JO - British Journal of Surgery

JF - British Journal of Surgery

SN - 0007-1323

IS - 3

ER -